BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19202741)

  • 1. Evaluation of the bioequivalence of two faropenem formulations in healthy Indian subjects.
    Bhaumik U; Ghosh A; Chakrabarty US; Mandal U; Bose A; Das A; Ray KK; Pal TK
    Arzneimittelforschung; 2008; 58(12):681-5. PubMed ID: 19202741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioavailability study of amisulpride tablets in healthy Indian volunteers.
    Das A; Bhaumik U; Chakrabarty US; Sarkar AK; Ghosh A; Bose A; Chatterjee B; Pal TK
    Arzneimittelforschung; 2009; 59(4):166-70. PubMed ID: 19517892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence study of levofloxacin tablets in healthy Indian volunteers using HPLC.
    Das A; Mukherjee J; Dey G; Sarkar AK; Sahoo BK; Chakrabarty US; Nandi U; Pal TK
    Arzneimittelforschung; 2011; 61(1):61-5. PubMed ID: 21355447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioequivalence study of a fixed dose combination of rabeprazole and itopride in healthy Indian volunteers.
    Sahoo BK; Das A; Agarwal S; Bhaumik U; Bose A; Ghosh D; Roy B; Pal TK
    Arzneimittelforschung; 2009; 59(9):451-4. PubMed ID: 19856792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence study of two tablet formulations containing rimonabant 20 mg in healthy Indian subjects.
    Nandi U; Bhaumik U; Chakrabarty US; Das A; Pal TK
    Arzneimittelforschung; 2011; 61(2):80-4. PubMed ID: 21428241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence study of two losartan formulations administered orally in healthy male volunteers.
    Bienert A; Brzezińiski R; Szałek E; Dubai V; Grześkowiak E; Dyderski S; Drobnik L; Wolc A; Olejniczak-Rabinek M
    Arzneimittelforschung; 2006; 56(11):723-8. PubMed ID: 17220048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioequivalence study of two cetirizine hydrochloride formulations in healthy Chinese male volunteers.
    Xu FG; Liu Y; Zhang ZJ; Tian Y; Chen Y
    Arzneimittelforschung; 2009; 59(9):440-4. PubMed ID: 19856790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability study of two cefixime formulations administered orally in healthy male volunteers.
    Zakeri-Milani P; Valizadeh H; Islambulchilar Z
    Arzneimittelforschung; 2008; 58(2):97-100. PubMed ID: 18412024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of two oral formulations of triflusal capsules in healthy volunteers.
    Quetglas EG; Campanero MA; Sádaba B; Escolar M; Azanza JR
    Arzneimittelforschung; 2008; 58(6):283-7. PubMed ID: 18677970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers.
    Chompootaweep S; Poonsrisawat J; Xumseang P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S79-85. PubMed ID: 17722305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence study of two azithromycin formulations in healthy subjects.
    Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Sari AP; Rimainar A
    Arzneimittelforschung; 2009; 59(9):471-5. PubMed ID: 19856795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence study of a fixed dose combination tablet containing rabeprazole and diclofenac sodium in healthy Indian subjects.
    Mukherjee J; Das A; Chakrabarty US; Sahoo B; Sengupta P; Chatterjee B; Roy B; Pal TK
    Arzneimittelforschung; 2010; 60(8):506-9. PubMed ID: 20863007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose bioequivalence study of alpha-methyldopa tablet formulations using a modified HPLC method.
    Valizadeh H; Nemati M; Hallaj-Nezhadi S; Ansarin M; Zakeri-Milani P
    Arzneimittelforschung; 2010; 60(10):607-11. PubMed ID: 21125810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence studies of film-coated tablet and chewable tablet generic formulations of montelukast in healthy volunteers.
    Cánovas M; Arcabell M; Martínez G; Canals M; Cabré F
    Arzneimittelforschung; 2011; 61(11):610-6. PubMed ID: 22232849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
    Joti JJ; Nahar K; Hasan A; Azad MA; Ullah MA; Islam SM; Hasnat A
    Arzneimittelforschung; 2009; 59(4):171-5. PubMed ID: 19517893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F
    Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence evaluation of cefdinir in healthy fasting subjects.
    Chen J; Jiang B; Lou H; Yu L; Ruan Z
    Arzneimittelforschung; 2012 Jan; 62(1):9-13. PubMed ID: 22331756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioequivalence evaluation of two brands of ciprofloxacin 500 mg tablets in Iranian healthy volunteers.
    Valizadeh H; Hamishehkar H; Ghanbarzadeh S; Zabihian N; Zakeri-Milani P
    Arzneimittelforschung; 2012 Dec; 62(12):566-70. PubMed ID: 23047470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioequivalence study of leflunomide tablets in Indian healthy volunteers.
    Agarwal S; Das A; Ghosh D; Sarkar AK; Chattaraj TK; Pal TK
    Arzneimittelforschung; 2012 Mar; 62(3):145-8. PubMed ID: 22278631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.